Membrane estrogen receptor alpha (ERα) participates in flow-mediated dilation in a ligand-independent manner
2021
Julie Favre | Emilie Vessieres | Anne-Laure Guihot | Coralyne Proux | Linda Grimaud | Jordan Rivron | Manuela CL Garcia | Léa Réthoré | Rana Zahreddine | Morgane Davezac | Chanaelle Fébrissy | Marine Adlanmerini | Laurent Loufrani | Vincent Procaccio | Jean-Michel Foidart | Gilles Flouriot | Françoise Lenfant | Coralie Fontaine | Jean-François Arnal | Daniel Henrion
Estrogen receptor alpha (ERα) activation by estrogens prevents atheroma through its nuclear action, whereas plasma membrane-located ERα accelerates endothelial healing. The genetic deficiency of ERα was associated with a reduction in flow-mediated dilation (FMD) in one man. Here, we evaluated ex vivo the role of ERα on FMD of resistance arteries. FMD, but not agonist (acetylcholine, insulin)-mediated dilation, was reduced in male and female mice lacking ERα (Esr1-/- mice) compared to wild-type mice and was not dependent on the presence of estrogens. In C451A-ERα mice lacking membrane ERα, not in mice lacking AF2-dependent nuclear ERα actions, FMD was reduced, and restored by antioxidant treatments. Compared to wild-type mice, isolated perfused kidneys of C451A-ERα mice revealed a decreased flow-mediated nitrate production and an increased H2O2 production. Thus, endothelial membrane ERα promotes NO bioavailability through inhibition of oxidative stress and thereby participates in FMD in a ligand-independent manner.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by Directory of Open Access Journals
